Melissa Myint is an experienced professional in the fields of biotechnology and chemical engineering. Current roles include ExploR&D Program Lead at Eli Lilly and Company and previously served as Project Team Lead for Fibrosis at Pioneering Medicines. Key positions held include Vice President of Exploratory Biology at Sonata Therapeutics, Director of Translational Research at Mana Therapeutics, and Associate Director of Immuno-Oncology Research at SQZ Biotechnologies, where extensive work on novel CellSqueeze technology was conducted. Melissa's educational background comprises a PhD in Chemical & Biomolecular Engineering from the University of Pennsylvania and a B.S. from Tufts University. Throughout the career, Melissa has developed expertise in product development, competitive analysis, and designing complex biological assays.
This person is not in the org chart
This person is not in any teams
This person is not in any offices